Company intelligence / Profile preview

Navigantis

Miami, Florida, United Statesnavigantis.co ↗

Ownership: Private
Development stage: Clinical

Overview

Navigantis has developed the VASCO robotic platform for neurovascular interventions. The company reported its first successful clinical cases in late 2024, including procedures such as diagnostic cerebral angiogram, brain tumor embolization, and mechanical thrombectomy for ischemic stroke. The device is investigational and currently undergoing clinical trials outside the United States.

Therapeutic areas: CardiovascularNeurology
Modalities: DeviceRobotic platform (surgical robotics)
Industry: Surgical Medical Devices

Drug pipeline

1 asset

VASCO

Clinical

Indications: Stroke, Aneurysm, Arteriovenous malformation

Beyond the preview

Go deeper on Navigantis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Navigantis.

Explore the full profile